Soluble CD146 (sCD146), a form of CD146 generated by ectodomain shedding of membrane CD146, can be detected within the serum derived from cancer patients and the cerebrospinal fluid (CSF) derived from patients with central nervous system diseases and was recently established as a diagnostic and predictive biomarker 33, 34. Here, MCAM is linked to central nervous system disorder.